Drug Shortage Report for CONSTELLA

Last updated on 2019-06-11 History
Report ID 84767
Drug Identification Number 02417162
Brand name CONSTELLA
Common or Proper name CONSTELLA 145MCG CAP 30 CA
Market Status MARKETED
Active Ingredient(s) Linaclotide
Strength(s) 145MCG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size CONSTELLA 145MCG CAP 30 CA
ATC code A06AX
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-05-24
Actual start date 2019-05-24
Estimated end date 2019-06-10
Actual end date 2019-06-10
Shortage status Resolved
Updated date 2019-06-11
Company comments Potential issue with the label
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-06-11 English Compare
v8 2019-06-10 French Compare
v7 2019-06-10 English Compare
v6 2019-06-06 French Compare
v5 2019-06-06 English Compare
v4 2019-05-27 French Compare
v3 2019-05-27 English Compare
v2 2019-05-25 French Compare
v1 2019-05-25 English Compare

Showing 1 to 9 of 9